Home/Corstasis Therapeutics/Amin Medjamia, MD

AM

Amin Medjamia, MD

VP Medical Affairs

Corstasis Therapeutics

Therapeutic Areas

Cardiovascular Nephrology Hepatology

Corstasis Therapeutics Pipeline

Drug	Indication	Phase
Undisclosed	Fluid overload in Congestive Heart Failure, Liver Disease, Kidney Disease	Preclinical

Leadership Team at Corstasis Therapeutics

Chief Scientific Officer

Brian Kolski, MD

Chief Medical Director

Stephen Diamond

Chief Business Officer

View full Corstasis Therapeutics profile